Detalhe da pesquisa
1.
Atopic dermatitis: A global health perspective.
J Eur Acad Dermatol Venereol
; 38(5): 801-811, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38151270
2.
Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies - Considerations for paediatric patients.
Australas J Dermatol
; 2024 May 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38741474
3.
Surveillance for Multisystem Inflammatory Syndrome in US Children Aged 5-11 Years Who Received Pfizer-BioNTech COVID-19 Vaccine, November 2021 through March 2022.
J Infect Dis
; 228(2): 143-148, 2023 07 14.
Artigo
Inglês
| MEDLINE | ID: mdl-36821777
4.
Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5-11 Years - United States, October 12-January 1, 2023.
MMWR Morb Mortal Wkly Rep
; 72(2): 39-43, 2023 Jan 13.
Artigo
Inglês
| MEDLINE | ID: mdl-36634021
5.
Exploration of associations between occupational exposures and current adult eczema.
Occup Environ Med
; 80(10): 564-571, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37797979
6.
Reporting rates for VAERS death reports following COVID-19 vaccination, December 14, 2020-November 17, 2021.
Pharmacoepidemiol Drug Saf
; 32(7): 763-772, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-36813704
7.
Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination-United States, December 2020 to August 2021.
Ann Intern Med
; 175(4): 513-522, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35038274
8.
Safety Surveillance of Varicella Vaccines in the Vaccine Adverse Event Reporting System, United States, 2006-2020.
J Infect Dis
; 226(Suppl 4): S431-S440, 2022 10 21.
Artigo
Inglês
| MEDLINE | ID: mdl-36265846
9.
Multisystem Inflammatory Syndrome in Adults After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Coronavirus Disease 2019 (COVID-19) Vaccination.
Clin Infect Dis
; 75(1): e741-e748, 2022 08 24.
Artigo
Inglês
| MEDLINE | ID: mdl-34849680
10.
Establishing subclasses of childhood eczema, their risk factors and prognosis.
Clin Exp Allergy
; 52(9): 1079-1090, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35347774
11.
The association between domestic hard water and eczema in adults from the UK Biobank cohort study.
Br J Dermatol
; 187(5): 704-712, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35822417
12.
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12-17 Years - United States, December 9, 2021-February 20, 2022.
MMWR Morb Mortal Wkly Rep
; 71(9): 347-351, 2022 Mar 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35239637
13.
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults - United States, September 22, 2021-February 6, 2022.
MMWR Morb Mortal Wkly Rep
; 71(7): 249-254, 2022 Feb 18.
Artigo
Inglês
| MEDLINE | ID: mdl-35176008
14.
Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5-11 Years - United States, May 17-July 31, 2022.
MMWR Morb Mortal Wkly Rep
; 71(33): 1047-1051, 2022 Aug 19.
Artigo
Inglês
| MEDLINE | ID: mdl-35980875
15.
Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status - United States, January 12, 2022-March 28, 2022.
MMWR Morb Mortal Wkly Rep
; 71(28): 899-903, 2022 Jul 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35834416
16.
Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ≥50 Years - United States, March 29, 2022-July 10, 2022.
MMWR Morb Mortal Wkly Rep
; 71(30): 971-976, 2022 Jul 29.
Artigo
Inglês
| MEDLINE | ID: mdl-35900925
17.
Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years - United States, August 31-October 23, 2022.
MMWR Morb Mortal Wkly Rep
; 71(44): 1401-1406, 2022 Nov 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36327162
18.
Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices - United States, December 2021.
MMWR Morb Mortal Wkly Rep
; 71(3): 90-95, 2022 Jan 21.
Artigo
Inglês
| MEDLINE | ID: mdl-35051137
19.
The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines - United States, February 2022.
MMWR Morb Mortal Wkly Rep
; 71(11): 416-421, 2022 Mar 18.
Artigo
Inglês
| MEDLINE | ID: mdl-35298454
20.
Management of atopic dermatitis: a narrative review.
Med J Aust
; 216(11): 587-593, 2022 06 20.
Artigo
Inglês
| MEDLINE | ID: mdl-35644531